donation
To request Mental Health
Services or to access Mental
Health Crisis Services Call:
1-800-375-4357

Medical Disorders
Resources
Basic InformationLookupsLatest News
Obesity Could Raise Odds for 'Long-Haul' COVID SymptomsSmokers, Obese People Need Major Heart Interventions Earlier in LifeOld Age No Bar to Successful Heart Transplant, Study FindsCOVID Antibody Treatment Is Safe, Effective in Transplant PatientsExpiration Dates on Johnson & Johnson COVID Vaccine ExtendedWill People Really Need a Yearly COVID Booster Vaccine?America Is Losing the War Against DiabetesGene Editing Technique Corrects Sickle Cell Disease in MiceCOVID Vaccines Appear Safe for People With IBDNew Treatment Fights Rare Cases of Vaccine-Linked Blood ClotsWoman Dies From Dengue Fever Acquired in FloridaWhy a COVID Diagnosis Could Cost You Way More Money in 2021Vaccinations More Urgent as Variant That Crippled India Shows Up in the U.S.Think You Can Skip That Annual Physical?  Think AgainReal-World Study Shows Power of Pfizer, Moderna Vaccines to Prevent COVIDDeath Rates Are Rising Across Rural AmericaWhat Diet Is Most Likely to Help Ease Crohn's Disease?'Breakthrough' COVID Infections May Be Common in Vaccinated Transplant PatientsPeople of Color Have Twice the Risk of Dying After Brain Injury, Study FindsStudy Pinpoints Cancer Patients at Highest Risk From COVIDMany Existing Drugs Could Be Potent COVID Fighters: StudyAntibiotics Won't Help Fight Lung-Scarring Disease IDF: StudyNew Disabilities Plague Half of COVID Survivors After Hospital DischargeDeclining Vaccination Rates Threaten Biden's July 4 GoalYour Doctor Appointments Might Look Different Post-PandemicPrior COVID Infection May Shield You From Another for at Least 10 MonthsTeens: You Got Your COVID Vaccine, What Now?White House Lists Countries Getting First Batch of Extra COVID VaccinesStrokes Hitting COVID Patients Are More Severe: StudyAverage COVID Hospital Bill for U.S. Seniors Nearly $22,000Deep Brain Stimulation Therapy May Help Parkinson's Patients Long TermNIH Starts Trial Assessing 'Mix & Match' COVID Vaccine ApproachAllergy Treatment Crucial If Your Child Has AsthmaScientists Discover Rare Form of ALS That Can Strike KidsGlobal Warming to Blame for 1 in 3 Heat-Related Deaths WorldwideBlood Sugar Tests Using Sweat, Not Blood? They Could Be on the WayU.S. Set to Send Millions of COVID Vaccines to Countries in NeedAs Teen, He Made News Opposing Anti-Vax Mom. Now, He's Urging COVID Shots for YouthSmog Might Damage Your Sense of SmellU.S. Blood Supply Is Safe From Coronavirus, Study FindsAmericans' Lung Health: The Poor Suffer MostLosing Weight Can Beat Diabetes and Also Help the HeartIs It COVID-19 or Seasonal Allergies?Many Americans Confused About Sunscreens: PollAnother Study Finds Routine Vaccines Safe for Kids, AdultsDon't Delay Lung Cancer Surgery, Study SuggestsPoll Finds Herd Immunity in U.S. Possible by SummerDebunking Myths That Have Some Parents Resisting COVID Vaccines for TeensExperimental Treatment Offers New Hope Against LupusMany Pre-Surgery Tests Are Useless, So Why Are Hospitals Still Using Them?
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

Poll Reveals Who's Most Vaccine-Hesitant in America and Why

HealthDay News
by Cara Murez
Updated: Apr 29th 2021

new article illustration

THURSDAY, April 29, 2021 (HealthDay News) -- U.S. resistance to getting a COVID-19 vaccine is slowly diminishing, a new online survey finds, but it still exists and at especially high rates in some blue-collar jobs.

For adults under age 65 who are hesitant, reluctance is mainly driven by concerns about safety, side effects and distrust in government, the poll found. It's also largely linked to people's line of work.

The bottom line: "Vaccine hesitancy is emerging as a key barrier to ending the COVID-19 pandemic," said lead author Wendy King, associate professor of epidemiology in the University of Pittsburgh Graduate School of Public Health.

Identifying occupations with a high rate of vaccine hesitancy and understanding the reasons for it might help public health workers address concerns, she said.

"Our study indicates that messaging about COVID-19 vaccine safety and addressing trust are paramount," King said in a university news release.

King and researchers from the Delphi Group at nearby Carnegie Mellon University analyzed results from its ongoing COVID-19 survey in collaboration with the Facebook Data for Good group. About 1.2 million U.S. residents in Facebook's active user database complete the survey each month.

In January, the survey added a question about willingness to receive the vaccine.

This study was limited to working-age adults, because workplace outbreaks and spread of infection from workers to customers are public health threats. Many working-age adults also are more hesitant about getting a shot than older Americans.

While resistance persists, there was some encouraging news: Vaccine hesitancy fell from 27.5% in January to 22% in March, according to the survey.

The March survey included 732,308 people (median age: 35 to 44, meaning half were older, half younger). About 45% were male, 77% had some college education and 64% were white.

Nearly 48% of those who reported vaccine hesitancy expressed concern about side effects. More than one-third didn't think they needed the shot, didn't trust the government, were waiting to see if the vaccine was safe or didn't trust COVID-19 vaccines specifically. And 14.5% said they didn't like vaccines in general.

Workers in some occupations were more reluctant than others to take the jab. Hesitancy ranged from 9.6% among educators and people in life, physical or social sciences to a high of 46% among workers in construction, oil and gas extraction and mining. Hesitancy was nearly as high among workers in installation, maintenance, repair, farming, fishing or forestry.

In health care fields, pharmacists were the least hesitant at 8.5%. The highest hesitancy, 20.5%, was among medical assistants, emergency medical technicians and home health, nursing, psychiatric or personal-care aides.

"The survey has grown to collect data on symptoms, illness, treatment, testing, behaviors like masking and distancing, and mental health," said senior author Robin Mejia, from Carnegie Mellon's Dietrich College of Humanities and Social Sciences. "And it's continuing to evolve as new policy questions arise."

The survey results were posted April 24 on the preprint server medRxiv and have not been peer-reviewed.

More information

The U.S. Centers for Disease Control and Prevention has more information on COVID-19 and vaccinations.

SOURCE: University of Pittsburgh, news release, April 28, 2021